Oracle has received final regulatory clearance for its pending $28.3 billion purchase of the healthcare data company Cerner. The deal is expected to close Monday.
The final step in the regulatory process was approval from the European Commission, which has now been received, the company said.
Oracle announced the deal, its biggest ever, in December last year. It will give it access to a trove of data and could attract more healthcare clients to its cloud platform.
Cerner, a hospital facility management software-maker, produces high-end health information technology services, devices, and hardware that rely on complex troves of patient data to help navigate various aspects of the US healthcare system, including availability and coverage of medical professionals to help people get the best coverage available.
Cerner’s data can help Oracle train and improve the software maker’s artificial intelligence-based cloud services. The company, whose software traditionally ran in its customers’ data centers, has started shifting its service to cloud computing providers.
Tech giants such as Microsoft have ramped up investments in the healthcare sector, spurred by demand for cloud-based solutions during the pandemic.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
EU Conducts First-Ever Raids on a Company Under Foreign Subsidies Regulation
Apr 23, 2024 by
CPI
FTC Moves to Ban Non-Compete Agreements, Aiming to Boost Labor Mobility
Apr 23, 2024 by
CPI
Federal Judge Nods at $418M Deal in Real Estate Antitrust Suit
Apr 23, 2024 by
CPI
Mexican Watchdog Probes Amazon and Mercado Libre Over Loyalty Bundles
Apr 23, 2024 by
CPI
Competition Commission of India to Probe AI Landscape for Competition
Apr 23, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI